Eplerenone (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Eplerenone drug offered from Mylan Pharmaceuticals Inc.. This Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | eplerenone |
SUBSTANCE NAME: | EPLERENONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-03 |
END MARKETING DATE: | 0000-00-00 |
Eplerenone HUMAN PRESCRIPTION DRUG Details:
Item Description | Eplerenone from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2017-10-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-1030_a3f4afdc-0620-4899-ab4f-168fbfa446a8 |
PRODUCT NDC: | 0378-1030 |
APPLICATION NUMBER: | ANDA203896 |
Other EPLERENONE Pharmaceutical Manufacturers / Labelers: